Yahoo Web Search

Search results

    • Biotest wins FDA approval for plasma protein therapy

      Biotest wins FDA approval for plasma protein therapy

      Pharmaceutical Technology via Yahoo Finance· 18 hours ago

      Biotest, a subsidiary of Grifols, announced that the US FDA granted approval for its plasma protein therapy Yimmugo earlier today (17 June). Yimmugo is...

    • FDA Approves Merck's Vaccine For Adult Invasive Pneumococcal Disease

      Morningstar· 12 hours ago

      By Emon Reiser The Food and Drug Administration approved Merck's Capvaxive, a vaccine to prevent the invasive bacterial infection pneumococcal disease in adults age 50 or older. Merck said that across four Phase 3 studies, Capvaxive "demonstrated